You are using an older browser version. Please use a supported version for the best MSN experience.

Franklin Biotechnology Discovery Adv

FTDZX
135.95
+1.48
+1.10%
5/27/2016
5 Years
  • Previous Close

    134.47

  • Net Assets

    93.67M

  • Yield

    0.00%

  • Front load

    None

  • Expenses

    0.75%

  • Category

    Health

  • Morningstar Risk

    High

  • Morningstar Rating ★★★
Profile

Name of Issuer

Franklin Templeton Investments

Fund Style

Open

Fund Manager

Christopher Lee

Investment Style

Medium Growth

The investment seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The fund predominantly invests in equity securities, primarily common stock. In addition to its investments in biotechnology companies, the fund may also invest up to 20% of its net assets in equity or debt securities of any type of foreign or U.S. issuer. It is non-diversified.

Purchase Information

Initial Purchase 1,000,000
Initial Purchase: IRA NA
Initial Purchase: AIP NA

Inception

9/1/2009

AdChoices
AdChoices
AdChoices
image beaconimage beaconimage beacon